Udita Sharma
Udita Sharma
Investment Engagement Manager
Helped 500+ investors build
their investment thesis.

Why the Idea That “Good Healthcare Only Exists in Indian Big Cities” Is as Outdated as Landlines

India’s healthcare story has always been a tale of two worlds. On one side, gleaming hospitals in metro cities offered world-class treatment. On the other, millions in smaller towns and villages struggled with overcrowded government hospitals, long travel times, and limited access to specialists. But something has changed. Not with big policy shifts or billion-dollar infrastructure projects, but with something much quieter, something unfolding on phone screens, in local clinics, and through networks that didn’t exist a decade ago. A new breed of healthcare is taking root in Tier 2 and 3 cities, and it’s going to rewrite the investment playbook.

Healthcare has always been an expensive game. Hospitals in big cities attracted doctors, investors, and patients who could afford premium care. Smaller cities, in contrast, struggled with profitability. The costs of setting up hospitals, hiring specialists, and maintaining high standards were simply too high compared to what the local population could pay. So, healthcare investors did what was logical: they focused on urban centers. But logic changes when business models change. Today, it’s not about where the hospital is, it’s about where the patient is sitting when they get treated. And that shift is why the next big boom isn’t in Mumbai or Delhi. It’s happening in Indore, Raipur, Jodhpur, and hundreds of other cities where medical care is no longer dependent on a metro pin code.

A city like Bareilly or Coimbatore no longer needs a top-tier cardiologist on every street. It just needs a fast connection to one. Doctors in big hospitals now consult patients across the country through digital clinics set up in smaller cities. The screen in a clinic in Patiala can connect to an oncologist in Chennai, ensuring world-class advice without the patient traveling hundreds of kilometers. The local doctor still runs diagnostics and provides immediate care, but specialized consultation is now just a click away. Hospitals, once bound by geography, are expanding their reach without building expensive new facilities. This means Tier 2 and 3 cities are no longer an afterthought for premium healthcare, they are front and center in the expansion strategy.

For years, high-end diagnostics required expensive labs in major cities, leading to delays and added costs for patients outside metro areas. That model is vanishing fast. Portable diagnostic tools now allow local clinics to conduct advanced tests that once required a trip to a specialized center. A single device, connected to a cloud-based system, can process reports faster than traditional labs. Even imaging, which was historically limited to large hospitals, is becoming mobile—modern handheld ultrasound devices can do the work of machines that once needed an entire room. The result is a massive shift in where medical tests happen. Not in a few corporate hospitals, but in thousands of clinics spread across smaller cities. The waiting game for diagnostics is over.
.
Investors often chase the obvious. In healthcare, the obvious has always been large metro-based hospital chains and urban diagnostics centers. But the quiet revolution in smaller cities is where the real numbers are starting to stack up. Over 60% of India’s population lives in smaller cities and rural areas, yet these regions have historically received less than 30% of total healthcare investment. That gap is now closing. Medical spending in Tier 2 and 3 cities is growing at nearly twice the rate of metro cities. As disposable incomes rise and awareness increases, the willingness to pay for better healthcare is skyrocketing. More than half of India’s teleconsultations now happen outside metro areas. Five years ago, this number was negligible.

The smart money is already making moves. Hospital chains that once built only in metro cities are now opening satellite centers in smaller towns, not as a social initiative, but because the demand is there. Diagnostics companies are doubling down on local partnerships. Insurance companies, traditionally hesitant about expanding in non-metro regions, are now integrating digital-first healthcare policies for smaller cities. And it’s not just the large players. A new wave of health-tech companies is catering specifically to Tier 2 and 3 cities, ensuring that diagnostics, consultations, and follow-up care don’t require a six-hour train journey anymore.

The idea that “good healthcare only exists in big cities” is about to be as outdated as landlines. The best hospitals may still be in Mumbai, but the best care doesn’t have to be. Smaller cities are no longer waiting for healthcare to come to them, they are bringing healthcare to themselves. For investors, ignoring this shift means missing out on what could be the most important healthcare expansion in decades. And unlike the usual boom-and-bust cycles, this one isn’t built on speculation. It’s built on something far more solid: real patients, in real cities, getting real treatment without needing a metro address. The next billion-dollar healthcare opportunity? It’s sitting quietly in a town you’ve never thought about. But it won’t stay quiet for long.

Source – EY The AIdea of India 2025 – How Much Productivity Can GenAI Unlock in India

Frequently Asked Questions

Q: How is healthcare expanding beyond big cities in India?
A: Digital clinics, telemedicine, and portable diagnostics are making world-class healthcare accessible in smaller cities.
Q: Why are investors focusing on Tier 2 and 3 cities in India?
A: Medical spending in smaller cities is growing twice as fast as in metros, creating massive investment potential.
Q: What role does telemedicine play in India’s healthcare growth?
A: Telemedicine connects smaller cities to top doctors, reducing travel and making specialized care widely available.
Q: How are diagnostics evolving in non-metro areas?
A: Portable devices and cloud-based systems enable advanced diagnostics in local clinics, eliminating delays.
Q: Will Tier 2 and 3 cities shape the future of Indian healthcare?
A: Yes, rising demand, better technology, and investor interest are turning smaller cities into healthcare hubs.

Udita Sharma
Udita Sharma
Investment Engagement Manager
Helped 500+ investors build
their investment thesis.

TERMS OF USE

Thank you for your interest in our Website at https://unlistedintel.com/. Your use of this Website, including the content, materials and information available on or through this Website (together, the “Materials”), is governed by these Terms of Use (these “Terms”). By using this Website, you acknowledge that you have read and agree to these Terms.

NO OFFER, SOLICITATION OR ADVICE

Our site is provided for informational purposes only. It does not constitute to constitute (i) an offer, or solicitation of an offer, to

purchase or sell any security, other assets, or service, (ii) investment, legal, business, or tax advice, or an offer to provide such advice or (iii) a basis for making any investment decision.

The Materials are provided for informational purposes and have been prepared by Oister Global for informational purposes to acquaint existing and prospective underlying funds, entrepreneurs, and other company founders with Oister Global's recent and historical investment activities.

Please note that any investments or portfolio companies referenced in the Materials are illustrative and do not reflect the performance of any Oister Global fund as a whole. There is no obligation for Oister Global to update or alter any forward-looking statements, whether as a result of new information, future events, or otherwise.

PURPOSE LIMITATION AND ACCESS TO YOUR PERSONAL DATA:

We will only collect your personal data in a fair, lawful, and transparent manner. We will keep your personal data accurate and up to date. We will process your personal data in line with your legal rights. We use your name and contact details, such as email, postal address, and contact number to continue communications with you. We may also use your contact information to invite you to events we are hosting or to keep you updated with our news.

USE OF COOKIES OR SIMILAR DEVICES

We use cookies on our website. This helps us to provide you with a better experience when you browse our website and also allows us to make improvements to our site. You may be able to change the preferences on your browser or device to prevent or limit your device’s acceptance of cookies, but this may prevent you from taking advantage of some of our features.

MATERIAL

The material displayed on our site is provided “as is”, without any guarantees, conditions, or warranties as to its accuracy, completeness, or reliability. You should be aware that a significant portion of the Materials includes or consists of information that has been provided by third parties and has not been validated or verified by us. In connection with our investment activities, we often become subject to a variety of confidentiality obligations to funds, investors, portfolio companies, and other third parties. Any statements we make may be affected by those confidentiality obligations, with the result that we may be prohibited from making full disclosures.

MISCELLANEOUS

This Website is operated and controlled by Oister Global in India. We may change the content on our site at any time. If the need arises, we may suspend access to our site, or close it indefinitely. We are under no obligation to update any material on our site.

CONTACT INFORMATION

Any questions, concerns or complaints regarding these Terms should be sent to info@oisterglobal.com

Campaign btn